Biote (BTMD) EBITDA Margin (2021 - 2026)

Biote (BTMD) has reported EBITDA Margin for 6 consecutive years, with 7.49% the latest figure, recorded in Q1 2026.

• In Q1 2026, EBITDA Margin rose 750.0% year-over-year to 7.49%; the TTM figure through Mar 2026 stood at 4.67% (up 318.0% YoY), while the FY2025 annual figure was 4.31%, up 380.0% from the prior year.
• EBITDA Margin came in at 7.49% for Q1 2026 at Biote, up from 44.45% in the prior quarter.
• The five-year high for EBITDA Margin was 154.4% in Q4 2022, with the low at 206.21% in Q2 2022.
• Average EBITDA Margin over 5 years is 3.21%, with a median of 0.02% recorded in 2022.
• Across the five-year window, EBITDA Margin tumbled 20624 bps in 2022 and jumped 20621 bps in 2023, its largest moves.
• Year by year, EBITDA Margin stood at 154.4% in 2022, then tumbled by 92 bps to 12.27% in 2023, then sank by 555 bps to 55.89% in 2024, then increased by 20 bps to 44.45% in 2025, then soared by 117 bps to 7.49% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 7.49%, 44.45%, and 17.66% for Q1 2026, Q4 2025, and Q3 2025 respectively.